CAH : Summary for Cardinal Health, Inc. Common St - Yahoo Finance

U.S. Markets closed

Cardinal Health, Inc. (CAH)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
73.04+1.93 (+2.71%)
At close: 4:00 PM EST
People also watch:
ABCMCKBAXBDXBCR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close71.11
Open0.00
Bid72.99 x 1000
Ask73.01 x 1300
Day's Range71.10 - 73.29
52 Week Range62.70 - 91.23
Volume3,048,168
Avg. Volume3,212,481
Market Cap23.38B
Beta0.79
PE Ratio (TTM)17.68
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.80 (2.51%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Forbes3 days ago

    Trump Doesn't Like Health Care But You Should, 2 Stocks To Buy

    "We know that the time to be greedy is when others are fearful and fearful when others are greedy, so we do not mind seeing AAII Bullish levels diminish nor are we unhappy to see the exodus from bonds slow somewhat.."

  • American City Business Journals3 days ago

    Cardinal Health more than doubled cash offer for Lymphoseek rights during negotiations with Navidea

    Cardinal Health Inc. more than doubled its guaranteed cash offer for Lymphoseek rights during this summer's negotiations with Navidea Biopharmaceuticals Inc., even as the biotech company was fighting for its survival with a creditor in court . Cardinal in June had offered $45 million cash for the North American rights to the radioactive cancer diagnostic aid , with any future payments contingent on drug sales, according to a proxy statement Navidea filed this week seeking shareholder approval of the sale . Navidea (NAVB) expects the deal to close about Jan. 10.

  • Is Cardinal Health Inc (CAH) A Good Stock To Buy?
    Insider Monkey9 days ago

    Is Cardinal Health Inc (CAH) A Good Stock To Buy?

    Before we spend many hours researching a company, we’d like to analyze what hedge funds and billionaire investors think of the stock first. We would like to do so because the elite investors’ consensus returns have been exceptional. The top 30 mid-cap stocks among the best performing hedge funds in our database yielded an average […]